Glycemic Effects of Morning Only, Evening Only or Twice Daily Insulin Glargine in Patients With Type 1 Diabetes

NCT00869414 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

16

Enrollment

OTHER

Sponsor class

Stopped PI deceased

Conditions

Type 1 Diabetes
Hypoglycemia

Interventions

DRUG: Evening only administration of insulin glargine
DRUG: Morning only administration of insulin glargine
DRUG: split dose insulin glargine

Sponsor

Johns Hopkins University